Sansure Biotech (688289.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov25

Alibaba Health and Shentech Biopharmaceuticals Sign Strategic Cooperation Agreement

09:55

Oct30

Sansure Biotech released FY2025 9 Months Earnings on October 30 After-Market (BJT), Actual Revenue CNY 1.244 B, Actual EPS CNY 0.3102

01:00

Sansure Biotech released FY2025 Q3 earnings on October 30 After-Market BJT, actual revenue CNY 375.52 M, actual EPS CNY 0.0296

01:00

Oct23

Sansure Biotech FY2025 Q3 Earnings Release on October 31 After-Market BJT

00:38

Aug29

Sansure Biotech released FY2025 Q2 earnings on August 29 Pre-Market (BJT), actual revenue CNY 393.13 M, actual EPS CNY 0.1205

01:00

Sansure Biotech released FY2025 Semi-Annual Earnings on August 29 Pre-Market (BJT), actual revenue CNY 868.62 M, actual EPS CNY 0.28

01:00

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 375.52 M, Net Income 28.6 M, EPS 0.0296

Aug30

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 393.13 M, Net Income 70.98 M, EPS 0.1205

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More